CNS Pharmacology USMLE Step 1 Practice Question
A 62-year-old woman with unstable angina undergoes urgent percutaneous coronary intervention. She receives an intravenous antiplatelet agent and subsequently develops a platelet count of 78,000/μL. Her vital signs are BP 138/82, HR 94, RR 16, temperature 37.2°C, and SpO2 98% on room air. She denies bleeding or bruising. The drug blocks the final common pathway of platelet aggregation by inhibiting the glycoprotein IIb/IIIa receptor. Which agent was most likely administered?
Answer choices
- AAspirin
- BBivalirudin
- CClopidogrel
- DWarfarin
- EAbciximabCorrect answer
- FEptifibatide
See the full explanation
Get the correct-answer rationale, why each distractor is wrong, the underlying mechanism, and high-yield associations — plus adaptive practice that targets your weak areas — with a free MedBoardPRO account.